AOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApprovedAOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApproved

Studies

The papers I'm actually reading. Recent research on every compound here, newest first. Read the abstracts before you trust anyone's marketing.

StudyBiomaterials advances · 2026-11-01

Hierarchical regulation and mechanism of "open-hollow-fibrous network" structures: Osteogenic-angiogenic coupling responses of poly(γ-benzyl-L-glutamate) microspheres

StudyJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026-10-01

Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke

StudyProceedings of the National Academy of Sciences of the United States of America · 2026-08-11

AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice

StudyEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026-08-04

Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis

StudyDiabetes, obesity & metabolism · 2026-08-04

GLP-1 Receptor Agonist Therapy for Obesity Under Japan's Optimal Use Guideline: A Prospective Real-World Study of Lifestyle Pre-Treatment, Time-Limited Treatment Cap, and Post-Cessation Regain

StudyJournal of diabetes investigation · 2026-08-04

Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis

Studynpj metabolic health and disease · 2026-08-03

Overweight and obesity induce Toll-like receptor 2-induced Type I IFN signaling

StudyMolecular and cellular biochemistry · 2026-08-03

Liraglutide affects mitochondrial function and histone acetylation through the NQO1/SIRT3 pathway in diabetic kidney disease

StudyMicrobiology spectrum · 2026-08-03

Effects of liraglutide on gut bacterial community dynamics

StudyHepatology (Baltimore, Md.) · 2026-08-03

Weight reduction-dependent/-independent effects of survodutide on liver endpoints: Mediation analysis of a phase 2 trial in MASH

StudyLab animal · 2026-08-01

Retatrutide effects on diabetic rats' cognition

StudyExperimental physiology · 2026-08-01

Circulating mitochondrial-derived microproteins at rest and in response to an acute bout of endurance exercise in individuals with cerebral palsy

StudyExperimental physiology · 2026-08-01

Mitochondrial peptide MOTS-c suppresses systemic and cardiac inflammasome activation in a diabetic rat model

StudyJournal of the American Heart Association · 2026-07-31

Cardiovascular Effects of Glucagon Receptor Signaling Alone and Combined With Glucagon-Like Peptide-1 Receptor Signaling in Multiagonists: A Narrative Review With a Translational Focus

StudyThe Analyst · 2026-07-27

Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices

StudyDiabetes, obesity & metabolism · 2026-07-26

Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post hoc Analysis of REDEFINE 1

StudyNature metabolism · 2026-07-24

Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism

StudyJournal of radiation research · 2026-07-24

Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence

StudyEuropean journal of internal medicine · 2026-07-23

Retatrutide and the urinary tract infection signal: Is the answer hidden in timing?

StudyJoint diseases and related surgery · 2026-07-23

Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study

StudyAnalytical methods : advancing methods and applications · 2026-07-22

Comprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling

StudyReproductive biology · 2026-07-21

Humanin peptide ameliorates reproductive dysfunction and restores neuroendocrine mechanisms in SSRI-treated male rats

StudyeLife · 2026-07-20

RNA selectively modulates activity of virulent amyloid PSMα3 and host-defense LL-37 via phase separation and aggregation dynamics

StudyInternational journal of molecular sciences · 2026-07-19

Immunomodulatory Effects of Poly-D,L-Lactic Acid on LL-37-Driven Rosacea-like Inflammation via Suppression of mTORC1 Signaling